Address: Carrera 11 N 84-09 Floor 5th.
Apartado Aéreo No. 4028
Santa Fe de Bogotá, D.C.
Colombia
Tel: 0.000017817511175018
Web: http://www.boehringer-ingelheim.com/global_activities/americas/colombia.html
Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Learn more about the financial highlights, the corporate vision, the organisation, the Board of Managing Directors and the company’s history as well as our engagement for scientific, cultural and environmental purposes.
Boehringer Ingelheim is a research-driven group of companies dedicated to researching, developing, manufacturing and marketing pharmaceuticals that improve health and quality of life. Our business consists largely of Human pharmaceuticals (consisting of Prescription Medicines, Consumer Health Care and Biopharmaceuticals) as well as Pharma Chemicals and Animal Health
Prescription Medicines, Consumer Health Care and Biopharmaceuticals
Our last report was in 2009-2010 when the “social emergency crisis” happened. What would you say have been the most important changes in the health system since that time? The…
As a means of introduction, could you describe your background and how you became involved with Nutripharma in the first place? Nutripharma is a 12-year-old family company created by my…
Can you trace the evolution of the Colombian economy over the last few years? The Colombian economy is experiencing a time of significant growth with production and investment projects as…
Sr. Gutierrez, when we interviewed your father in 2010, he described to us the strong potential of the medical industry in Colombia in the future. Since that time, would you…
What is your background, and how did you become involved with Grupo Amarey? My first job in the medical industry was with Johnson & Johnson Medical, which back then was…
In our last meeting, you said that you were looking forward to a decade of continuous growth and to be the number one partner of choice for patients, physicians, governments…
The operations and sales managers of Cegedim Colombia discuss the impact of healthcare reform on the Colombian pharma market, partnering opportunities in the…
You have an extensive background in the healthcare sector, with positions in Colciencias, the Department of Public Health, and the National University of Colombia. What can you bring from these…
Dra. Cajigas, you were appointed Director General of INVIMA just over two years ago. What have been the biggest challenges that you have faced since the start of your tenure?…
An expert in trade and regulatory issues relating to the pharmaceutical industry in Colombia, the senior partner of Espíndola International Consultants offers his opinions on the steps taken by the Colombian…
Prior to working as General Manager of Sanofi Colombia, you worked in similar positions in Ecuador and Venezuela. What was your initial mission upon returning to Colombia and how have…
When we interviewed you in 2010, there were 182 pharmaceutical companies in Colombia, representing 2.5 percent of total Colombian manufacturing output (surpassing traditional industries such as sugar and coffee). As…
See our Cookie Privacy Policy Here
